A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk
Ulrika Andersson(Umeå University), Beatrice Melin(Umeå University), Spyros Tsavachidis(The University of Texas MD Anderson Cancer Center), Melissa L. Bondy(The University of Texas MD Anderson Cancer Center), Maria Feychting(Karolinska Institutet), Fredrik Wiklund(Statisticon (Sweden)), Anthony J. Swerdlow(Institute of Cancer Research), Anssi Auvinen(Tampere University of Applied Sciences), Judith Schwartzbaum(Karolinska Institutet), Stefan Lönn(Hallands sjukhus Halmstad), Anders Ahlbom(Karolinska Institutet), Christoffer Johansen(University of Copenhagen), Yanhong Liu(Sichuan University), Anne Kiuru(Radiation and Nuclear Safety Authority), Helle Collatz-Laier(Danish Cancer Society), Roger Henriksson(Umeå University), Sara Sjöström(Umeå University), Minouk J. Schoemaker(Institute of Cancer Research)
Cited by 88
Related Papers
Cost of disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|1.7k
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
|Nature Genetics|2018|1k
Genome-wide association study identifies five susceptibility loci for glioma
|Nature Genetics|2009|797